U.S. Radiopharmaceuticals Markets

 

Regular Price: USD 2,450

Special Price USD 1,715

30% OFF

* Required Fields

Regular Price: USD 2,450

Special Price USD 1,715

PAY BY INVOICE

Be the first to review this product

This report focuses on the dynamic radiopharmaceuticals (diagnostics and therapeutics) market including additional analysis of the FDG and Radiopharmacy segments. The report covers the markets for agents over an eleven year period, from 1998 to 2008, with the year 2001 as the base year. This report provides a comprehensive analysis of the revenue and procedure forecasts, competitive and market share analysis, and specific product analysis focusing on both existing and emerging products within the market segments. Additionally regional analysis is performed for the radiopharmacy market, including FDG radiopharmacies.

Table of Contents

U.S. Radiopharmaceuticals Markets, Executive SummaryMarket OverviewIntroductionU.S. Radiopharmaceuticals Markets, Total MarketOverviewIntroductionChallengesStrategic RecommendationsFrost & Sullivan Market Engineering AwardsEntrepreneurial Product Innovation - Boston Life Sciences Inc.Market Leadership - Radiodiagnostics - Bristol-Meyers Squibb Medical Imaging Inc.Product Line Strategy - Amersham Health Customer Service and Market Leadership - Radiopharmacies -Syncor InternationalStrategic Acquisition - ScheringU.S. Radiopharmaceuticals Markets, Diagnostic RadiopharmaceuticalsDiagnostic Radiopharmaceuticals OverviewIntroductionMarket DriversMarket RestraintsMarket Engineering AnalysisDiagnostic Radiopharmaceuticals Forecasts and TrendsRevenue ForecastsProcedure AnalysisDiagnostic Radiopharmaceuticals Competitive AnalysisCompetitive StructureMarket Share AnalysisCardiology Diagnostics Forecasts and TrendsIntroductionMarket Engineering AnalysisRevenue ForecastsProcedure AnalysisCardiology Diagnostics Competitive AnalysisCompetitive StructureProduct Analysis - Existing ProductsProduct Analysis - Emerging ProductsOther Diagnostics Forecasts and TrendsIntroductionMarket Engineering AnalysisRevenue ForecastsProcedure AnalysisOther Diagnostics Competitive AnalysisCompetitive StructureProduct Analysis - Existing ProductsProduct Analysis - Emerging ProductsU.S. Radiopharmaceuticals Markets, FDG MarketFDG Market OverviewIntroductionMarket DriversMarket RestraintsFDG Forecasts and TrendsRevenue ForecastsDemand AnalysisProducts in DevelopmentCompetitive AnalysisU.S. Radiopharmaceuticals Markets, Therapeutic RadiopharmaceuticalsTherapeutic Radiopharmaceuticals OverviewIntroductionMarket DriversMarket RestraintsMarket Engineering AnalysisTherapeutic Radiopharmaceutical Forecasts and TrendsRevenue ForecastsDemand AnalysisTherapeutic Radiopharmaceuticals Competitive AnalysisCompetitive StructureMarket Share AnalysisTherapeutic Radiopharmaceuticals Product AnalysisProduct Analysis - Existing ProductsProduct Analysis - Emerging ProductsRadioimmunotherapyAlpha Immunotherapy U.S. Radiopharmaceuticals Markets, RadiopharmaciesGeneral Radiopharmacy TrendsIntroductionRevenue Forecast and Demand AnalysisCompetitive AnalysisGeneral Radiopharmacy Regional TrendsRegional AnalysisCardiovascular Variable AnalysisCancer Incidence Variable AnalysisAge Variable AnalysisFDG Radiopharmacy TrendsIntroductionRevenue Forecast Competitive AnalysisFDG Radiopharmacy Regional TrendsRegional AnalysisCancer Variable AnalysisAnalysis of FDG and Installed Base of PET




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 20-Nov-17

Region : North America

Release Date : 07-Nov-17

Region : North America

Release Date : 06-Nov-17

Region : North America

Release Date : 31-Oct-17

Region : North America

Release Date : 31-Oct-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.